OGN:NYSE
Organon & Co
USD 13,90
arrow_downward
-0,07%(-0,0100) 1D
17 Nov., 09:49:08 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
USD 13,90
High
USD 13,90
Low
USD 13,89
Mkt. cap
3,65 mjd
Avg. vol.
2,55 m
Volume
52,50 k
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,07
52-wk high
USD 13,91
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
Open
USD 13,90
High
USD 13,90
Low
USD 13,89
Mkt. cap
3,65 mjd
Avg. vol.
2,55 m
Volume
52,50 k
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,07
52-wk high
USD 13,91
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
News stories
From web sources and news partners
ChartMill
·
1 uur gelede
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
The Motley Fool
·
23 minute gelede
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
FOREX.com
·
1 uur gelede
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Traders Union
·
40 minute gelede
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 k
Founded1923
HeadquartersJersey City, New Jersey, Verenigde State van Amerika
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com